Download Free Design Synthesis And Biological Evaluation Of Cell Permeable Small Molecule Probes Book in PDF and EPUB Free Download. You can read online Design Synthesis And Biological Evaluation Of Cell Permeable Small Molecule Probes and write the review.

Abstract : My thesis is focused on the development of fluorescent probes for biosensing and bioimaging within specific organelles. My main research efforts are mainly focused on the design, synthesis and biological applications of these new molecular probes. These new fluorescent probes I developed can be manipulated through the chemical modifications for binding to specific organelles capable of reporting localized bioinformation. Compared to the currently commercially available organelle-specific fluorescent stains, the advantages of the newly synthesized fluorescent probes include low cytotoxicity, high photostability, and long fluorescence lifetimes. These features are crucial for long-time tracking study of biological processes. Research on fluorescent probes with both analyte responsiveness and organelle targetability is a new and emerging area that has attracted increasing attention over the past few years. Because of their high sensitivity, specificity and fast response, these novel fluorescent probes have been proven to be useful tools for facilitating biomedical research. I have further extended the diversity by developing organelle-specific responsive probes capable of detecting changes in biomolecular levels and the microenvironment. My future research efforts give more considerations of the "low-concern" organelles, such as the Golgi apparatus, the endoplasmic reticulum, and ribosomes. Considering the tiny sizes of subcellular organelles, we anticipate that better visualization of the cellular events within specific organelles will rely on super-resolution optical microscopy with nanoscopic-scale resolution.
Cyclic ADR-Ribose Synthases (cADPRSs) are one of the NAD-consuming enzymes. It hydrolyzes and cyclizes NAD+ into ADPR and cADPR, which are both Ca2+ channel regulators. Since the activities of cADPRSs involves in multiple biological process, monitoring the activities of these enzymes can provide useful information for studying pathology of the diseases that are closely associated with these enzymes. In this thesis, we have designed and synthesized a series of small molecule probes which can undergo base exchange reaction with the nicotinamide group of NAD+ in the presence of CD38 or activated SARM1. A large red shift of emission wavelength occurred after the base exchange reaction, which provides a powerful tool for detecting activities of this class of enzymes. In the first project, these probes were applied to the detection of the activities of SARM1. Among the 23 probes prepared, PC6 and PC11 showed excellent sensitivity and selectivity in vitro. They are cell-permeant, yet the resulting exchange products are im-permeant, allowing imaging of activated SARM1 in live cells. PC6 has provided the first evidence that SARM1 activation precedes axon degeneration by several hours in live DRG neurons. Moreover, it was also applied in the library screening for SARM1 inhibitor. Dehydronitrosonisodipine (dHNN) was found to has the inhibition ability to SARM1 activation, which is also the first compound ever reported that can inhibit SARM1 activation. PC11 has better fluorescent properties than PC6. With larger absorption and emission wavelength, PC11 provided the first approach for imaging SARM1 activation in vivo. In the second project, we focused on the study of the catalytic mechanism of CD38. Based on the preliminary results of the theoretical studies, we proposed that CD38 catalyzed cyclization and hydrolysis of NAD+ may involve an epoxide intermediate. In this mechanistic study, we have employed our newly developed probe PC6, CD38 mutant and different model compounds. The results of this study strongly supported the hypothesis of an epoxide intermediate in CD38-catalyzed reactions.
This is an valuable introduction to medicinal chemistry for new graduates and PhDs. It will also serve to update more experienced scientists on the newer technologies in the field.
Fragment-based drug discovery is a rapidly evolving area of research, which has recently seen new applications in areas such as epigenetics, GPCRs and the identification of novel allosteric binding pockets. The first fragment-derived drug was recently approved for the treatment of melanoma. It is hoped that this approval is just the beginning of the many drugs yet to be discovered using this fascinating technique. This book is written from a Chemist's perspective and comprehensively assesses the impact of fragment-based drug discovery on a wide variety of areas of medicinal chemistry. It will prove to be an invaluable resource for medicinal chemists working in academia and industry, as well as anyone interested in novel drug discovery techniques.
Reactive oxygen species (ROS) have been implicated in almost every human disease phenotype, without much, if any, therapeutic consequence foremost exemplified by the failure of the so-called anti-oxidants. This book is a game changer for the field and many clinical areas such as cardiology and neurology. The term ‘oxidative stress’ is abandoned and replaced with a systems medicine and network pharmacology-based mechanistic approach to disease. The ROS-related drugs discussed here target either ROS- forming or ROS -modifying enzymes for which there is strong clinical evidence. In addition, ROS targets are included as they jointly participate in causal mechanisms of disease. This approach is transforming the ROS field and represents a breakthrough in redox medicine indicating a path to patient benefit. In the coming years more targets and drugs may be discovered, but the approach will remain the same and this book will thus become, and for many years remain, the leading reference for ROSopathies and their treatment by network pharmacology. Chapter "Soluble Guanylate Cyclase Stimulators and Activators" is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.